Moderna
MRNA
#1188
Rank
NZ$27.91 B
Marketcap
$72.54
Share price
0.79%
Change (1 day)
-57.55%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -NZ$3.87 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$5.05 Billion. In 2023 the company made an earning of -NZ$6.91 Billion a decrease over its 2022 earnings that were of NZ$16.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$3.87 Billion-43.93%
2023 -NZ$6.91 Billion-140.65%
2022 NZ$16.97 B-27.81%
2021 NZ$23.51 B-1911.15%
2020 -NZ$1.3 Billion44.7%
2019 -NZ$0.9 Billion28.63%
2018 -NZ$0.7 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$73.13 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.46 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$73.82 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.34 Billion-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.50 B-646.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$1.03 Billion-75.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.51 B-889.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA